SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Haggar Axana)
 

Search: WFRF:(Haggar Axana) > (2015-2016) > Six-week follow-up ...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Gaines, HansKarolinska Institutet,Public Health Agency of Sweden, Solna, Sweden; Dept Med, Infect Dis Unit, Karolinska Institute, Stockholm, Sweden; Dept Infect Dis, Karolinska Univ Hosp, Stockholm, Sweden (author)

Six-week follow-up after HIV-1 exposure: a position statement from the Public Health Agency of Sweden and the Swedish Reference Group for Antiviral Therapy

  • Article/chapterEnglish2016

Publisher, publication year, extent ...

  • 2015-09-28
  • Informa UK Limited,2016

Numbers

  • LIBRIS-ID:oai:research.chalmers.se:d041bd0b-8270-474a-844f-e2082b95f084
  • https://research.chalmers.se/publication/236143URI
  • https://doi.org/10.3109/23744235.2015.1089593DOI
  • https://lup.lub.lu.se/record/8034666URI
  • https://gup.ub.gu.se/publication/236143URI
  • https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-56364URI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:133167372URI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:for swepub-publicationtype
  • Subject category:ref swepub-contenttype

Notes

  • In 2014 the Public Health Agency of Sweden and the Swedish Reference Group for Antiviral Therapy (RAV) conducted a review and analysis of the state of knowledge on the duration of follow-up after exposure to human immunodeficiency virus (HIV). Up until then a follow-up of 12 weeks after exposure had been recommended, but improved tests and new information on early diagnosis motivated a re-evaluation of the national recommendations by experts representing infectious diseases and microbiology, county medical officers, the RAV, the Public Health Agency, and other national authorities. Based on the current state of knowledge the Public Health Agency of Sweden and the RAV recommend, starting in April 2015, a follow-up period of 6 weeks after possible HIV-1 exposure, if HIV testing is performed using laboratory-based combination tests detecting both HIV antibody and antigen. If point-of-care rapid HIV tests are used, a follow-up period of 8 weeks is recommended, because currently available rapid tests have insufficient sensitivity for detection of HIV-1 antigen. A follow-up period of 12 weeks is recommended after a possible exposure for HIV-2, since presently used assays do not include HIV-2 antigens and only limited information is available on the development of HIV antibodies during early HIV-2 infection. If pre- or post-exposure prophylaxis is administered, the follow-up period is recommended to begin after completion of prophylaxis. Even if infection cannot be reliably excluded before the end of the recommended follow-up period, HIV testing should be performed at first contact for persons who seek such testing.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Albert, JanKarolinska Institutet,Swedish Reference Group for Antiviral Therapy,Karolinska University Hospital,Dept Microbiol Tumor & Cell Biol, Karolinska Institute, Stockholm, Sweden; Dept Clin Microbiol, Karolinska Univ Hosp, Stockholm, Sweden; Swedish Reference Grp Antiviral Therapy, Stockholm, Sweden (author)
  • Axelsson, MariaFolkhälsomyndigheten,Public Health Agency of Sweden,Public Health Agency of Sweden, Solna, Sweden (author)
  • Berglund, TorstenKarolinska Institutet (author)
  • Gisslén, Magnus,1962Gothenburg University,Göteborgs universitet,University of Gothenburg,Swedish Reference Group for Antiviral Therapy,Institutionen för biomedicin, avdelningen för infektionssjukdomar,Institute of Biomedicine, Department of Infectious Medicine,Swedish Reference Grp Antiviral Therapy, Stockholm, Sweden; Dept Infect Dis, Sahlgrenska Acad, Univ Gothenburg, Gothenburg, Sweden(Swepub:gu)xgissm (author)
  • Sonnerborg, A.Karolinska Institutet,Swedish Reference Group for Antiviral Therapy,Karolinska University Hospital,Dept Infect Dis, Karolinska Univ Hosp, Stockholm, Sweden; Dept Clin Microbiol, Karolinska Univ Hosp, Stockholm, Sweden; Swedish Reference Grp Antiviral Therapy, Stockholm, Sweden; Div Clin Microbiol, Dept Lab Med, Karolinska Institute, Stockholm, Sweden (author)
  • Blaxhult, AndersKarolinska Institutet (author)
  • Bogdanovic, GordanaKarolinska universitetssjukhuset,Karolinska University Hospital,Dept Clin Microbiol, Karolinska Univ Hosp, Stockholm, Sweden (author)
  • Brytting, MariaFolkhälsomyndigheten,Public Health Agency of Sweden,Public Health Agency of Sweden, Solna, Sweden (author)
  • Carlander, ChristinaKarolinska Institutet (author)
  • Flamholc, LeoLund University,Lunds universitet,Enheten för infektionssjukdomar,Forskargrupper vid Lunds universitet,Infectious Diseases Research Unit,Lund University Research Groups,Swedish Reference Group for Antiviral Therapy,Swedish Reference Grp Antiviral Therapy, Stockholm, Sweden; Dept Infect Dis, Skåne Univ Hosp, Lund Univ, Malmö, Sweden(Swepub:lu)inf-lfl (author)
  • Follin, PerVästra Götalandsregionen,Region Västra Götaland,The County of Västra Götaland,Dept Communicable Dis Control & Prevent, Region Västra Götaland, Gothenburg, Sweden (author)
  • Haggar, AxanaSocialstyrelsen,National Board of Health and Welfare,Socialstyrelsen / Swedish National Board of Health and Welfare,Natl Board Hlth & Welf, Stockholm, Sweden (author)
  • Hagstam, PerLund University,Lunds universitet,Infektionsmedicin,Sektion III,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Infection Medicine (BMC),Section III,Department of Clinical Sciences, Lund,Faculty of Medicine,Dept Communicable Dis Control & Prevent, Malmö, Sweden(Swepub:lu)infek-ph (author)
  • Johansson, Marcus,1975Kalmar County Hospital,Dept Clin Microbiol & Infect Dis, Kalmar Cty Hosp, Kalmar, Sweden(Swepub:cth)kf95020 (author)
  • Navér, LarsKarolinska Institutet,Karolinska University Hospital,Swedish Reference Group for Antiviral Therapy,Swedish Reference Grp Antiviral Therapy, Stockholm, Sweden; Dept Pediat, Karolinska Univ Hosp, Stockholm, Sweden; Dept Clin Sci Intervent & Technol, Karolinska Institute, Stockholm, Sweden (author)
  • Persson Blom, JennySwedish Reference Group for Antiviral Therapy,Swedish Work Environment Authority, Stockholm, Sweden (author)
  • Samuelson, AgnetaKarolinska Institutet (author)
  • Ström, Helena,1985Socialstyrelsen,National Board of Health and Welfare,Socialstyrelsen / Swedish National Board of Health and Welfare,Natl Board Hlth & Welf, Stockholm, Sweden (author)
  • Sundqvist, MartinRegion Örebro län,Clin Microbiol, Örebro University Hospital, Örebro, Sweden(Swepub:oru)mist (author)
  • Svedhem Johansson, VeronicaKarolinska Institutet (author)
  • Tegmark Wisell, KarinKarolinska Institutet,Public Health Agency of Sweden, Solna, Sweden (author)
  • Tegnell, AndersKarolinska Institutet,Public Health Agency of Sweden, Solna, Sweden (author)
  • Thorstensson, RigmorKarolinska Institutet,Public Health Agency of Sweden, Solna, Sweden (author)
  • Karolinska InstitutetPublic Health Agency of Sweden, Solna, Sweden; Dept Med, Infect Dis Unit, Karolinska Institute, Stockholm, Sweden; Dept Infect Dis, Karolinska Univ Hosp, Stockholm, Sweden (creator_code:org_t)

Related titles

  • In:Infectious Diseases: Informa UK Limited48:2, s. 93-982374-42352374-4243

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view